Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TERT | O14746 | 1/20 | 0.69 |
| ▸ | MAPT | P10636 | 6/20 | 0.67 |
| ▸ | BCHE | P06276 | 2/20 | 0.67 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.67 |
| ▸ | ABCG2 | Q9UNQ0 | 2/20 | 0.65 |
| ▸ | CYP1B1 | Q16678 | 2/20 | 0.65 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.64 |
| ▸ | MEN1 | O00255 | 2/20 | 0.64 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.64 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.64 |
| ▸ | HPGD | P15428 | 2/20 | 0.64 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.64 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.64 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.64 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.64 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.64 |
| ▸ | THRB | P10828 | 1/20 | 0.64 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.64 |
| ▸ | GUSB | P08236 | 1/20 | 0.64 |
| ▸ | MAOB | P27338 | 3/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL634100 | 1.00 | TERT (0.69) | TERTMAPTBCHECYP2C19ABCG2 | |
| SCHEMBL27579527 | 0.90 | MAPT (0.77) | MAPTBCHECYP2C19ABCG2CYP1B1 | |
| SCHEMBL27497473 | 0.85 | MAPT (0.65) | TERTMAPTBCHECYP2C19ABCG2 | |
| SCHEMBL30736439 | 0.84 | TERT (0.70) | TERTMAPTABCG2KDM4EMEN1 | |
| SCHEMBL2541146 | 0.84 | TERT (0.70) | TERTMAPTABCG2KDM4EMEN1 | |
| SCHEMBL2541144 | 0.84 | TERT (0.70) | TERTMAPTABCG2KDM4EMEN1 | |
| SCHEMBL31436349 | 0.84 | TERT (0.70) | TERTMAPTABCG2KDM4EMEN1 | |
| SCHEMBL17975287 | 0.83 | NFE2L2 (0.63) | MAPTBCHECYP2C19ABCG2CYP1B1 | |
| SCHEMBL31436357 | 0.83 | TERT (0.69) | TERTMAPTCYP2C19ABCG2CYP1B1 | |
| SCHEMBL31436334 | 0.83 | TERT (0.69) | TERTMAPTCYP2C19CYP1B1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 317 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190008797-A1 | ESTROGEN RECEPTOR ALPHA COLIGANDS, AND METHODS OF USE THEREOF | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2019-01-10 | — | — | US | claimed |
| CN-101143861-A | B ring 4'-single substituted flavone compounds, preparation method and use | SHANGHAI INST MATERIA MEDICA (CN) | 2008-03-19 | — | — | CN | claimed |
| WO-1998027970-A2 | TREATMENT OF DISEASES OR PREVENTION OF CELLULAR DAMAGE CAUSED BY OXYGEN-CONTAINING FREE RADICALS | NATIONAL RESEARCH COUNCIL OF CANADA (CA) | 1998-07-02 | — | — | WO | claimed |
| US-20260033492-A1 | Pest Repellents and Uses Thereof | SENSORYGEN INC (US) | 2026-02-05 | — | — | US | disclosed |
| US-20250228795-A1 | ESTROGENIC COMPOUNDS AND METHODS OF USE | IATERION, INC. | 2025-07-17 | — | — | US | disclosed |
| EP-4561560-A1 | ESTROGENIC COMPOUNDS AND METHODS OF USE | Iaterion, Inc. (US) | 2025-06-04 | — | — | EP | disclosed |
| US-12280129-B2 | Compositions and methods for improved skin care | PINSKY MARK A (US) | 2025-04-22 | — | — | US | disclosed |
| WO-2024026034-A1 | ESTROGENIC COMPOUNDS AND METHODS OF USE | IATERION, INC. (US) | 2024-02-01 | — | — | WO | disclosed |
| US-20230292754-A1 | Pest Repellents and Uses Thereof | UNIVERSITY OF CALIFORNIA RIVERSIDE | 2023-09-21 | — | — | US | disclosed |
| US-20220117863-A1 | COMPOSITIONS AND METHODS FOR IMPROVED SKIN CARE | PINSKY MARK A (US) | 2022-04-21 | — | — | US | disclosed |
| US-20210338558-A1 | USE OF COLLAGEN BINDING DOMAINS TO DELIVER PRODUCTS TO SKIN | FABIUS BIOTECHNOLOGY (US) | 2021-11-04 | — | — | US | disclosed |
| WO-2000062743-A2 | SKIN CARE COMPOSITIONS CONTAINING COMBINATION OF SKIN CARE ACTIVES | THE PROCTER & GAMBLE COMPANY (US) | 2000-10-26 | — | — | WO | disclosed |
| WO-2000062742-A2 | METHODS FOR REGULATING THE CONDITION OF MAMMALIAN KERATINOUS TISSUE | THE PROCTER & GAMBLE COMPANY (US) | 2000-10-26 | — | — | WO | disclosed |
| WO-2000062745-A2 | SKIN CARE COMPOSITIONS CONTAINING COMBINATION OF SKIN CARE ACTIVES | THE PROCTER & GAMBLE COMPANY (US) | 2000-10-26 | — | — | WO | disclosed |
| WO-2000062741-A2 | SKIN CARE COMPOSITIONS CONTAINING COMBINATION OF SKIN CARE ACTIVES | THE PROCTER & GAMBLE COMPANY (US) | 2000-10-26 | — | — | WO | disclosed |
| US-6093411-A | AN EMULSION COMPRISING FLAVONOIDS FOR PREVENTING OR TREATING SKIN DISORDERS | THE PROCTER & GAMBLE COMPANY (US) | 2000-07-25 | — | — | US | disclosed |
| US-6051602-A | METHODS FOR PREVENTION OR TREATING SKIN DISORDERS USING FLAVONOID COMPOUNDS | THE PROCTER & GAMBLE COMPANY (US) | 2000-04-18 | — | — | US | disclosed |
| WO-1999047118-A1 | COMPOSITIONS FOR REGULATING SKIN APPEARANCE | THE PROCTER & GAMBLE COMPANY (US) | 1999-09-23 | — | — | WO | disclosed |
| WO-1999047113-A1 | COMPOSITIONS FOR REGULATING SKIN APPEARANCE | THE PROCTER & GAMBLE COMPANY (US) | 1999-09-23 | — | — | WO | disclosed |
| WO-1999047119-A1 | METHODS FOR REGULATING SKIN APPEARANCE | THE PROCTER & GAMBLE COMPANY (US) | 1999-09-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210338558-A1 | USE OF COLLAGEN BINDING DOMAINS TO DELIVER PRODUCTS TO SKIN | COL14A1, COL2A1, COL1A1 | TERT 4123/4885MAPT 1503/4885BCHE 2640/4885 |
| US-20190008797-A1 | ESTROGEN RECEPTOR ALPHA COLIGANDS, AND METHODS OF USE THEREOF | ESRRG, GPER1, ESR2 | TERT 4625/4885MAPT 4210/4885BCHE 948/4885 |
| US-20260033492-A1 | Pest Repellents and Uses Thereof | F3, TFPI, FLI1 | TERT 57/4885MAPT 122/4885BCHE 641/4885 |
| US-20250228795-A1 | ESTROGENIC COMPOUNDS AND METHODS OF USE | ESR1, ESR2, CYP19A1 | TERT 3056/4885MAPT 2361/4885BCHE 762/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.